Search Results

Site Search

Leveraging the Laboratory: Seize Tomorrow - Insights

Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.

Leveraging the Laboratory: Seize Tomorrow - Insights

Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.

Leveraging the Laboratory: Seize Tomorrow - Insights

Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.

Mayo Clinic Laboratory and Pathology Research Roundup: June 25 - Insights

This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.

Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 15 - Insights

This week’s Research Roundup highlights how the loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion.

Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 4 - Insights

This week’s Research Roundup highlights individual patient-level meta-analysis of the performance of the Decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease.

Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 21 - Insights

This week’s Research Roundup highlights how intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.

Mayo Clinic Discovers Biological Markers That Could Guide Treatment for Prostate Cancer - Insights

Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, Mayo Clinic has discovered.

National Stop The Bleed Day - Insights

Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, talks about the importance of National Stop The Bleed Day, a national awareness campaign about the top cause of preventable death in trauma.

Staffing to Workload in Phlebotomy Areas: Off-Site Operational Needs - Insights

Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on off-site operational needs, including paid time off and unpaid time off.